BryanJMShethNHeifermanMJ.Trends in antivascular endothelial growth factor injections among Medicare Part B beneficiaries in 2013–2021 and the step therapy era. J Vitreoretin Dis. 2026;10(2):194-201.
2.
AbbasASingaraveluJFeinJG.Real-world clinical usage and safety profile of intravitreal pegcetacoplan in age-related macular degeneration-associated geographic atrophy. J Vitreoretin Dis. 2026;10(2):202-210.
3.
MomenaeiBWakabayashiTAdamsOE, et al. Short-term changes in intraocular pressure following intravitreal injection of pegcetacoplan. J Vitreoretin Dis. 2026;10(2):211-216.
4.
AdreanSDHillLAmador-PatarroyoJ.Fibrosis in patients with choroidal neovascularization based on spectral-domain optical coherence tomography: findings from the HARBOR trial. J Vitreoretin Dis. 2026;10(2):217-222.
5.
DursunEInancMKocerAMDursunAGATekinK.Long-term effects of smoking on retinal and choriocapillaris perfusion: an optical coherence tomography angiography study. J Vitreoretin Dis. 2026;10(2):223-229.
6.
HuDJPandiriSChaayaC, et al. Environmental and financial cost savings with low-consumption intravitreal injection techniques. J Vitreoretin Dis. 2026;10(2):230-237.
7.
VargheseDCampagnaGElwoodK, et al. Exogenous hormone use as a predictor of central serous chorioretinopathy recurrence: a comparative analysis of observation versus low-fluence photodynamic therapy. J Vitreoretin Dis. 2026;10(2):238-245.
8.
DinhRHZhangHPanR, et al. Volumetric optical coherence tomography analysis of visual and surgical outcomes in patients with full-thickness macular hole. J Vitreoretin Dis. 2026;10(2):246-253.
9.
DukeRCTFischerNACrossonJNAlbertMA JrFeistRMMasonJOIII. Long-term outcomes on quality of life following sutureless vitrectomy for symptomatic vitreous floaters. J Vitreoretin Dis. 2026;10(2):254-260.
10.
SaeedOBHassanMMillerDM, et al. Management and outcomes of bilateral simultaneous rhegmatogenous retinal detachments. J Vitreoretin Dis. 2026;10(2):261-269.
11.
RohowetzLJMcSoleyMJSalazarH, et al. Clinical features and outcomes of fishing-related ocular injuries. J Vitreoretin Dis. 2026;10(2):270-276.
12.
HerskowitzWRLaiJMNguyenB, et al. Long-term outcomes of 4-point expanded polytetrafluoroethylene and 2-point polypropylene fixation of scleral-sutured intraocular lenses. J Vitreoretin Dis. 2026;10(2):277-284.
13.
ChiangLWakabayashiTMahmoudzadehR, et al. Outcomes of retinectomy for proliferative vitreoretinopathy: comparison of phakic eyes without lensectomy and pseudophakic eyes. J Vitreoretin Dis. 2026;10(2):285-293.
14.
GopalADSoaresRRMomenaeiB, et al. Characteristics of uveitis specialists and disparities in geographic access to uveitis care in the United States. J Vitreoretin Dis. 2026;10(2):294-302.
15.
BerkowitzSTFinnAPThomasASNoreLAkinRGangaputraS.A time-driven activity-based costing analysis of new uveitis patient visits. J Vitreoretin Dis. 2026;10(2):303-309.
16.
LooysenTKramerMEmersonG.Scleral imbrication sutures provide temporary or sustained vitreous base indentation as an adjuvant to pars plana vitrectomy for retinal detachment repair. J Vitreoretin Dis. 2026;10(2):310-316.
17.
ShahSda CruzNFSSengilloJ. Schisis-like presentations of familial exudative vitreoretinopathy caused by FZD4 mutations. J Vitreoretin Dis. 2026;10(2):317-322.
18.
SperberJHoyekSChaayaCPandiriSPatelNA.Late reactivation of retinopathy in a treatment-naive female adult patient with history of prematurity and ZNF408 mutation. J Vitreoretin Dis. 2026;10(2):323-327.
19.
Arias-GonzálezNKiryakozaLFernandezMP, et al. Immediate sequential bilateral retinal detachment repair in a patient with suspected COL2A1 and APC mutations. J Vitreoretin Dis. 2026;10(2):328-332.
20.
JabaraJWestBGovindarajuVKFaiaLJ.Bilateral peripheral neovascularization in hemoglobin C trait retinopathy. J Vitreoretin Dis. 2026;10(2):333-336.
21.
KesavamoorthyNSaberMSSuEJungeJARaoNAmeriH.Postmortem retinal structural and metabolic analysis after human embryonic stem cell–derived retinal pigment epithelium transplantation in a patient with Stargardt disease. J Vitreoretin Dis. 2026;10(2):337-343.
22.
ZhangEBylundRZhangAMassopD.Alpha-gal syndrome allergy to intravitreal administration of antivascular endothelial growth factor agents. J Vitreoretin Dis. 2026;10(2):344-349.
23.
KhanSADuJAliMHJohnsonTM.Scedosporium apiospermum as a causative organism of chronic endophthalmitis following uncomplicated cataract surgery. J Vitreoretin Dis. 2026;10(2):350-354.
24.
Abu SerhanHNaeemUMohamedMSIAl HashimiMPaiA.Sub-internal limiting membrane hemorrhage following femtosecond laser in situ keratomileusis: a rare postoperative complication. J Vitreoretin Dis. 2026;10(2):355-358.
25.
ChenMYOsmanDHAbou-SamraABarraTAByrnesGAliMH.Valsalva retinopathy secondary to habitual ear popping in the setting of chronic bilateral eustachian tube dysfunction. J Vitreoretin Dis. 2026;10(2):359-362.
